Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects

by Fabrizio Schifano
Published 2020-03-01

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon

by Fabrizio Schifano
Published 2018-12-01

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs

by Stefania Chiappini, Fabrizio Schifano
Published 2020-10-01

Is There a Potential of Misuse for Venlafaxine and Bupropion?

by Fabrizio Schifano, Stefania Chiappini
Published 2018-03-01

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

by Fabrizio Schifano, Stefania Chiappini
Published 2018-01-01

Piloting the UK’s First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service

by Amira Guirguis, Rosalind Gittins, Fabrizio Schifano
Published 2020-07-01

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites.

by Imanollah Bigdeli, Ornella Corazza, Zoe Aslanpour, Fabrizio Schifano
Published 2013-05-01

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK

by Rosalind Gittins, Amira Guirguis, Fabrizio Schifano, Ian Maidment
Published 2018-03-01

Ruboxistaurin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Clinical Trials

by Dipika Bansal, Yogesh Badhan, Kapil Gudala, Fabrizio Schifano
Published 2013-10-01

Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008–2012)

by Dipika Bansal, Anil Bhagat, Fabrizio Schifano, Kapil Gudala
Published 2019-04-01

The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review

by Safia Sharif, Amira Guirguis, Suzanne Fergus, Fabrizio Schifano
Published 2021-03-01

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

by Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis
Published 2020-02-01

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

by Fabrizio Schifano, Stefania Chiappini, John Martin Corkery, Amira Guirguis
Published 2019-02-01

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

by Fabrizio Schifano, Stefania Chiappini, John M. Corkery, Amira Guirguis
Published 2018-04-01

Statin use and risk of prostate cancer: a meta-analysis of observational studies.

by Dipika Bansal, Krishna Undela, Sanjay D'Cruz, Fabrizio Schifano
Published 2012-01-01

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction

by Stefania Chiappini, Stefania Chiappini, Fabrizio Schifano, Giovanni Martinotti, Giovanni Martinotti
Published 2021-04-01

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis

by Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano
Published 2021-07-01

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

by Stefania Chiappini, Amira Guirguis, Amira Guirguis, Ann John, John Martin Corkery, Fabrizio Schifano
Published 2020-07-01

Sexual Enhancement Products for Sale Online: Raising Awareness of the Psychoactive Effects of Yohimbine, Maca, Horny Goat Weed, and Ginkgo biloba

by Ornella Corazza, Giovanni Martinotti, Rita Santacroce, Eleonora Chillemi, Massimo Di Giannantonio, Fabrizio Schifano, Selim Cellek
Published 2014-01-01

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity

by Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano
Published 2021-07-01